Literature DB >> 3931142

Tryptophan depletion causes a rapid lowering of mood in normal males.

S N Young, S E Smith, R O Pihl, F R Ervin.   

Abstract

Normal male human subjects ingested amino acid mixtures which were tryptophan-free, balanced or contained excess tryptophan. The tryptophan-free mixture causes a marked depletion of plasma tryptophan by 5 h. At this time the subjects in the tryptophan-free group had significantly elevated scores on the depression scale of the Multiple Affect Adjective Checklist. The tryptophan-free group also performed worse than the other two groups in a proofreading task carried out while listening to a tape with themes of hopelessness and helplessness (dysphoric distractor). Cognitive theories of depression predict greater distractability of depressed individuals by dysphoric themes. Thus, both measures indicate a rapid mood lowering effect of tryptophan depletion in normal males. This effect is probably mediated by a lowering of brain 5-hydroxytryptamine. Although the mood-lowering effect was not as great as that seen in depressed patients, our results suggest that low brain 5HT might be one factor precipitating depression in some patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931142     DOI: 10.1007/bf00431803

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Central-nervous-system effects of ingestin of L-tryptophan by normal subjects.

Authors:  B SMITH; D J PROCKOP
Journal:  N Engl J Med       Date:  1962-12-27       Impact factor: 91.245

Review 2.  The brain serotonergic system in the affective disorders.

Authors:  D L Murphy; I C Campbell; J L Costa
Journal:  Prog Neuropsychopharmacol       Date:  1978

3.  Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism.

Authors:  G L Gessa; G Biggio; F Fadda; G U Corsini; A Tagliamonte
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

4.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

5.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

6.  Central serotonin metabolism and frequency of depression.

Authors:  H M van Praag; S de Haan
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

7.  Clinical-pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent.

Authors:  V Y Cremata; B K Koe
Journal:  Clin Pharmacol Ther       Date:  1966 Nov-Dec       Impact factor: 6.875

8.  Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome.

Authors:  K Engelman; W Lovenberg; A Sjoerdsma
Journal:  N Engl J Med       Date:  1967-11-23       Impact factor: 91.245

9.  Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients.

Authors:  B Shopsin; E Friedman; S Gershon
Journal:  Arch Gen Psychiatry       Date:  1976-07

10.  CSF monoamine metabolites of depressed patients during illness and after recovery.

Authors:  L Träskman-Bendz; M Asberg; L Bertilsson; P Thorén
Journal:  Acta Psychiatr Scand       Date:  1984-04       Impact factor: 6.392

View more
  144 in total

1.  Landmark publications in Psychopharmacology: the first 40 years.

Authors:  K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

Review 2.  Pathophysiology of seasonal affective disorder: a review.

Authors:  R W Lam; R D Levitan
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

3.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Authors:  Marco Leyton; Valerie Kwai Pun; Chawki Benkelfat; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

5.  Effects of acute tryptophan depletion on neural processing of facial expressions of emotion in humans.

Authors:  Eileen Daly; Quinton Deeley; Brian Hallahan; Michael Craig; Michael Brammer; Melissa Lamar; Anthony Cleare; Vincent Giampietro; Christine Ecker; Lisa Page; Fiona Toal; Mary L Phillips; Simon Surguladze; Declan G M Murphy
Journal:  Psychopharmacology (Berl)       Date:  2010-04-28       Impact factor: 4.530

6.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

7.  Serotonin revisited.

Authors:  Philip J Cowen; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

Review 8.  The neuroprotective effects of cocoa flavanol and its influence on cognitive performance.

Authors:  Astrid Nehlig
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 9.  The use of diet and dietary components in the study of factors controlling affect in humans: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

10.  Chronic MDMA (ecstasy) use, cognition and mood.

Authors:  K McCardle; S Luebbers; J D Carter; R J Croft; C Stough
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.